Browsing by Author Vissel, B

Showing results 1 to 20 of 24  next >
Issue DateTitleAuthor(s)
26-Sep-2017Maternal Cigarette Smoke Exposure Worsens Neurological Outcomes in Adolescent Offspring with Hypoxic-Ischemic Injury.Chan, YL; Saad, S; Machaalani, R; Oliver, BG; Vissel, B; Pollock, C; Jones, NM; Chen, H
May-2017New hope for devastating neurodegenerative disease.Stayte, S; Vissel, B
27-Apr-2017The meteorology of cytokine storms, and the clinical usefulness of this knowledge.Clark, IA; Vissel, B
Apr-2017Dissociation between complete hippocampal context memory formation and context fear acquisition.Leake, J; Zinn, R; Corbit, L; Vissel, B
2017Activin A Inhibits MPTP and LPS-Induced Increases in Inflammatory Cell Populations and Loss of Dopamine Neurons in the Mouse Midbrain In Vivo.Stayte, S; Rentsch, P; Tröscher, AR; Bamberger, M; Li, KM; Vissel, B
12-Feb-2016A Comparative Study of Variables Influencing Ischemic Injury in the Longa and Koizumi Methods of Intraluminal Filament Middle Cerebral Artery Occlusion in Mice.Morris, GP; Wright, AL; Tan, RP; Gladbach, A; Ittner, LM; Vissel, B
Jan-2016Excess cerebral TNF causing glutamate excitotoxicity rationalizes treatment of neurodegenerative diseases and neurogenic pain by anti-TNF agents.Clark, IA; Vissel, B
Aug-2015Amyloid β: one of three danger-associated molecules that are secondary inducers of the proinflammatory cytokines that mediate Alzheimer's disease.Clark, IA; Vissel, B
22-Apr-2015Activin A protects midbrain neurons in the 6-hydroxydopamine mouse model of Parkinson's disease.Stayte, S; Rentsch, P; Li, KM; Vissel, B
Jan-2015A Neurologist's Guide to TNF Biology and to the Principles behind the Therapeutic Removal of Excess TNF in Disease.Clark, IA; Vissel, B
18-Sep-2014Inconsistencies and controversies surrounding the amyloid hypothesis of Alzheimer's disease.Morris, GP; Clark, IA; Vissel, B
22-May-2014Advances in non-dopaminergic treatments for Parkinson's disease.Stayte, S; Vissel, B
21-Mar-2014Inflammation-sleep interface in brain disease: TNF, insulin, orexin.Clark, IA; Vissel, B
Oct-2013Treatment implications of the altered cytokine-insulin axis in neurodegenerative disease.Clark, IA; Vissel, B
Oct-2013Microglia: a new frontier for synaptic plasticity, learning and memory, and neurodegenerative disease research.Morris, GP; Clark, IA; Zinn, R; Vissel, B
Jun-2013Prefrontal microcircuit underlies contextual learning after hippocampal loss.Zelikowsky, M; Bissiere, S; Hast, TA; Bennett, RZ; Abdipranoto, A; Vissel, B; Fanselow, MS
1-Apr-2013Neuroinflammation and neuronal loss precede Aβ plaque deposition in the hAPP-J20 mouse model of Alzheimer's disease.Wright, AL; Zinn, R; Hohensinn, B; Konen, LM; Beynon, SB; Tan, RP; Clark, IA; Abdipranoto, A; Vissel, B
Oct-2012Tumor necrosis factor-induced cerebral insulin resistance in Alzheimer's disease links numerous treatment rationales.Clark, I; Atwood, C; Bowen, R; Paz-Filho, G; Vissel, B
Jan-2012The essential role of AMPA receptor GluR2 subunit RNA editing in the normal and diseased brain.Wright, A; Vissel, B
1-Dec-2011Alzheimer's disease selective vulnerability and modelling in transgenic miceGötz, J; Schonrock, N; Vissel, B; Ittner, LM; Casadesus, G